Patient engagement services (PES) are no longer downstream support functions — they are established commercial levers for launch performance, shaping how patients access therapy, stay adherent, and engage throughout the treatment journey. As therapies grow more complex and patient expectations rise, leading organizations are embedding engagement models directly into commercialization strategy from the outset.

In this webinar, we will explore how direct-to-patient (DTP) models have become a powerful commercial pathway for accelerating patient access, reducing friction in the treatment journey, generating actionable insights, and improving launch uptake and brand performance.